Invasive pulmonary fungal disease (IPFD) has emerged as a significant global public health concern, posing a serious threat to human health. Early and accurate diagnosis is crucial for improving patient prognosis. This article aims to systematically review the core challenges in IPFD diagnosis, highlight recent advances in emerging technologies, and discuss their implications for optimizing clinical therapeutic decision-making, drawing on the latest research findings and practical clinical experience.